Abstract
Background
Oils enriched in gammalinolenic acid, an unsaturated fatty acid, reduce joint pain and swelling in patients with rheumatoid arthritis. The cytokines interleukin-1β and tumor necrosis factor-α appear to contribute directly to joint tissue damage in patients with rheumatoid arthritis. Agents designed to interfere with the actions of interleukin-1β and tumor necrosis factor-α are being used to treat rheumatoid arthritis.
Methods
We examined the influence of gammalinolenic acid added to cells in vitro and administered orally in vivo on interleukin-1β and tumor necrosis factor-α secretion from activated human peripheral blood monocytes. Secretion of both cytokines was reduced by gammalinolenic acid. Administration of safflower oil as a polyunsaturated fatty acid control devoid of gammalinolenic acid did not change secretion of either cytokine.
Conclusion
Suppression of IL-β and TNF-α secretion by activated cells may be one mechanism whereby gammalinolenic acid suppresses synovitis in patients with rheumatoid arthritis.
Get full access to this article
View all access options for this article.